Synovitis and pannus formation were significantly reduced in the anti-IL-6 mAb treated mice as compared to that of the control mAb treated mice in the current study, indicating the efficacy of the anti-IL-6 mAb in suppressing histological degradation in this RA model. The gene discussed is IL6; the disease is synovitis.